UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 944

Sortiert nach

Apport et méthodologies innovantes des essais de phase I en oncologie thoracique : des phases 1 aux essais BASKET/plateforme

Revue des maladies respiratoires actualités, 2022-10, Vol.14 (2), p.2S138-2S145

Massard, C.

2022

Link zum Volltext

Verfügbarkeit prüfen

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)

Annals of oncology, 2013-07, Vol.24 (7), p.1807-1812

2013

Link zum Volltext

Verfügbarkeit prüfen

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

European journal of cancer (1990), 2016-02, Vol.54, p.139-148

2016

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study

Annals of oncology, 2018-08, Vol.29 (8), p.1807-1813

2018

Link zum Volltext

Verfügbarkeit prüfen

SP-0554: Novel immunotherapeutic drugs in clinical trials

Radiotherapy and oncology, 2014, Vol.111, p.S217-S217

Massard, C

2014

Link zum Volltext

Verfügbarkeit prüfen

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor

Annals of oncology, 2019-08, Vol.30 (8), p.1401-1403

2019

Link zum Volltext

Verfügbarkeit prüfen

Tumeurs rénales du sujet jeune : expérience monocentrique

Progrès en urologie (Paris), 2015-11, Vol.25 (13), p.798-799

2015

Link zum Volltext

Verfügbarkeit prüfen

First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

Annals of oncology, 2018-09, Vol.29 (9), p.1911-1917

2018

Link zum Volltext

Verfügbarkeit prüfen

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

British journal of cancer, 2011-09, Vol.105 (6), p.847-853

2011

Link zum Volltext

Verfügbarkeit prüfen

Problématique des tumeurs rares: une nouvelle rubrique du Bulletin du cancer

Bulletin du cancer, 2010-09, Vol.97 (9), p.1031-1039

2010

Link zum Volltext

Verfügbarkeit prüfen

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance

Annals of oncology, 2021-11, Vol.32 (11), p.1381-1390

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression

European journal of cancer (1990), 2018-09, Vol.101, p.160-164

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4906-4911

2010

Link zum Volltext

Verfügbarkeit prüfen

Tumour stem cell-targeted treatment: elimination or differentiation

Annals of oncology, 2006-11, Vol.17 (11), p.1620-1624

2006

Link zum Volltext

Verfügbarkeit prüfen

Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?

Annals of oncology, 2010-12, Vol.21 (12), p.2324-2332

2010

Link zum Volltext

Verfügbarkeit prüfen

Prise en charge des complications cardiovasculaires des traitements en oncologie thoracique

Revue des maladies respiratoires, 2014-02, Vol.31 (2), p.173-180

2014

Link zum Volltext

Verfügbarkeit prüfen

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

BMC cancer, 2016-02, Vol.16 (168), p.168-168, Article 168

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidence of brain metastases in renal cell carcinoma treated with sorafenib

Annals of oncology, 2010-05, Vol.21 (5), p.1027-1031

2010

Link zum Volltext

Verfügbarkeit prüfen

Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patients

Annals of oncology, 2020-12, Vol.31 (12), p.1782-1784

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors

Cancer chemotherapy and pharmacology, 2022-10, Vol.90 (4), p.335-344

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

Annals of oncology, 2021-12, Vol.32 (12), p.1642-1645

2021

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential

OncoTargets and therapy, 2019-04, Vol.12, p.2505-2512

2019

Link zum Volltext

Verfügbarkeit prüfen

Thérapies moléculaires ciblées dans le cancer du poumon à petites cellules

Bulletin du cancer, 2010-05, Vol.97 (5), p.535-545

2010

Link zum Volltext

Verfügbarkeit prüfen

Recent developments in treatments targeting castration-resistant prostate cancer bone metastases

Annals of oncology, 2012-05, Vol.23 (5), p.1085-1094

2012

Link zum Volltext

Verfügbarkeit prüfen

Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: A reality or a myth?

Annals of oncology, 2018-10, Vol.29, p.viii713-viii713

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 944

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(842)
Mit Volltextzugriff
(839)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Life Sciences & Biomedicine
(193)
Humans
(171)
Oncology
(117)
Male
(115)
Middle Aged
(80)
Female
(79)
Aged
(74)
Sciences Biologiques Et Medicales
(65)
Sciences Medicales
(64)
Adult
(61)
Biological And Medical Sciences
(61)
Medical Sciences
(57)
Hematology, Oncology And Palliative Medicine
(43)
Tumors
(42)
Treatment Outcome
(36)
Cancer
(33)
Life Sciences
(33)
Surgery
(33)
Tumeurs
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(224)
Bulletin Du Cancer
(90)
Journal Of Clinical Oncology
(33)
European Journal Of Cancer
(30)
L'homme
(27)
Revue Des Maladies Respiratoires
(27)
Annuaire De L'ehess
(20)
Oncologie
(19)
European Journal Of Cancer Supplements
(16)
Revue De Pneumologie Clinique
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Apport et méthodologies innovantes des essais de phase I en oncologie thoracique : des phases 1 aux essais BASKET/plateforme

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study

SP-0554: Novel immunotherapeutic drugs in clinical trials

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor

Tumeurs rénales du sujet jeune : expérience monocentrique

First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

Problématique des tumeurs rares: une nouvelle rubrique du Bulletin du cancer

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance

Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Tumour stem cell-targeted treatment: elimination or differentiation

Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?

Prise en charge des complications cardiovasculaires des traitements en oncologie thoracique

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

Incidence of brain metastases in renal cell carcinoma treated with sorafenib

Sequential treatment with NOTCH inhibitor crenigacestat followed by pazopanib in soft tissue sarcoma patients

A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential

Thérapies moléculaires ciblées dans le cancer du poumon à petites cellules

Recent developments in treatments targeting castration-resistant prostate cancer bone metastases

Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: A reality or a myth?

Suchergebnisse filtern